Influence of visceral obesity on oncologic outcome in patients with renal cell carcinoma

Urologia Internationalis

Volumn 85, Issue 1, 2010, Pages 30-36

  Naya, Yukio ^a   Zenbutsu, Satoki ^a   Araki, Kazuhiro ^a   Nakamura, Kazuyoshi ^a   Kobayashi, Masayuki ^a   Kamijima, Syuichi ^a   Imamoto, Takashi ^a   Nihei, Naoki ^a   Suzuki, Hiroyoshi ^a   Ichikawa, Tomohiko ^a   Igarashi, Tatsuo ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Oncologic outcome; Renal cell carcinoma; Visceral obesity

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INTRAABDOMINAL FAT; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; OBESITY; OUTCOME ASSESSMENT; PARTIAL NEPHRECTOMY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; SMOKING;

ADIPOSITY; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; HUMANS; INTRA-ABDOMINAL FAT; JAPAN; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEPHRECTOMY; OBESITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77955703763     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000318988     Document Type: Article

References (34)

1. Marumo K, Kanayama H, Miyao N, et al: Prevalence of renal cell carcinoma: a nationwide survey in Japan, 2002. Int J Urol 2007; 14: 479-482.
2. Hollingsworth JM, Miller DC, Daignault S, et al: Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006; 98: 1331-1334.
3. Moore LE, Wilson RT, Campleman SL: Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review. Cancer Invest 2005; 23: 240-255.
4. Hunt JD, van der Hel OL, McMillan GP, et al: Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer 2005; 114: 101-108.
5. Heath CW Jr, Lally CA, Calle EE, et al: Hypertension, diuretics, and antihypertensive medications as possible risk factors for renal cell cancer. Am J Epidemiol 1997; 145: 607-613.
6. Chow WH, Gridley G, Fraumeni JF Jr, et al: Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med 2000; 343: 1305-1311.
7. Awakura Y, Nakamura E, Ito N, et al: Influence of body mass index on prognosis of Japanese patients with renal cell carcinoma. Urology 2007; 70: 50-54.
8. Haferkamp A, Pritsch M, Bedke J, et al: The influence of body mass index on the longterm survival of patients with renal cell carcinoma after tumour nephrectomy. BJU Int 2008; 101: 1243-1246.
9. Yoshiike N, Matsumura Y, Zaman MM, et al: Descriptive epidemiology of body mass index in Japanese adults in a representative sample from the National Nutrition Survey 1990-1994. Int J Obes Relat Metab Disord 1998; 22: 684-687.
10. Ogden CL, Carroll MD, Curtin LR, et al: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-1555.
11. Poirier P, Despres JP: Waist circumference, visceral obesity, and cardiovascular risk. J Cardiopulm Rehabil 2003; 23: 161-169.
12. Klein S: The case of visceral fat: argument for the defense. J Clin Invest 2004; 113: 1530-1532.
13. Goodpaster BH, Krishnaswami S, Resnick H, et al: Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care 2003; 26: 372-379.
14. Kanaya AM, Harris T, Goodpaster BH, et al: Adipocytokines attenuate the association between visceral adiposity and diabetes in older adults. Diabetes Care 2004; 27: 1375-1380.
15. Wajchenberg BL: Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697-738.
16. Bacha F, Saad R, Gungor N, et al: Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 2004; 27: 547-552.
17. Saijo Y, Kiyota N, Kawasaki Y, et al: Relationship between C-reactive protein and visceral adipose tissue in healthy Japanese subjects. Diabetes Obes Metab 2004; 6: 249-258.
18. Kuk JL, Lee S, Heymsfield SB, Ross R: Waist circumference and abdominal adipose tissue distribution: influence of age and sex. Am J Clin Nutr 2005; 81: 1330-1334.
19. Shen W, Punyanitya M, Wang Z, et al: Visceral adipose tissue: relations between single- slice areas and total volume. Am J Clin Nutr 2004; 80: 271-278.
20. Park HS, Lee K: Greater beneficial effects of visceral fat reduction compared with subcutaneous fat reduction on parameters of the metabolic syndrome: a study of weight reduction programmes in subjects with visceral and subcutaneous obesity. Diabet Med 2005; 22: 266-272.
21. Sass DA, Schoen RE, Weissfeld JL, et al: Relationship of visceral adipose tissue to recurrence of adenomatous polyps. Am J Gastroenterol 2004; 99: 687-693.
22. Kuskowska-Wolk A, Karsson P, Stolt M, et al: The predictive validity of body mass index based on self-reported weight and height. Int J Obes 1989; 13: 441-453.
23. Kaaks R, Lukanova A: Energy balance and cancer: the role of insulin and insulin-like growth factor-I. Proc Nutr Soc 2001; 60: 91-106.
24. Cheung CW, Vesey DA, Nicol DL, et al: The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. Kidney Int 2004; 65: 1272-1279.
25. Calle EE, Kaaks R: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-591.
26. Hall JE, Brands MW, Henegar JR: Mechanisms of hypertension and kidney disease in obesity. Ann NY Acad Sci 1999; 892: 91-107.
27. Karelis AD, St-Pierre DH, Conus F, et al: Metabolic and body composition factors in subgroups of obesity: what do we know? J Clin Endocrinol Metab 2004; 89: 2569-2575.
28. Dusserre E, Moulin P, Vidal H: Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 2000; 1500: 88-96.
29. Yu ML, Asal NR, Geyer JR: Later recurrence and longer survival among obese patients with renal cell carcinoma. Cancer 1991; 68: 1648-1655.
30. Kamat AM, Shock RP, Naya Y, Rosser CJ, Slaton JW, Pisters LL: Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors. Urology 2004; 63: 46-50.
31. Rasmuson T, Grankvist K, Jacobsen J, et al: Serum insulin-like growth factor-1 is an independent predictor of prognosis in patients with renal cell carcinoma. Acta Oncol 2004; 43: 744-748.
32. Trayhurn P: Endocrine and signaling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 2005; 184: 285-293.
33. La Cava A, Alviggi C, Matarese G: Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med 2004; 82: 4-11.
34. Onishi T, Ohishi Y, Goto H, et al: An assessment of the immunological status of patients with renal cell carcinoma based on the relative abundance of T-helper-1 and -2 cytokine- producing CD4- cells in peripheral blood. BJU Int 2001; 87: 755-759.